About the company
Contact us
Hydroxyapatite for injection
Hydroxyapatite for chromatography
Life Science & Aesthetics
中
中 | EN
Frequently asked questions


How are proteins categorized?

1   By types

1.1 细胞因子和生长因子(Cytokines/Growth Factors)

1.2 免疫检查点蛋白(Immune Checkpoint Proteins)

1.3 CAR-T相关蛋白(CAR-T Related Proteins)

1.4 CD抗原(CD Antigens)

1.5 Fc受体蛋白(Fc Receptor Proteins)

1.6 受体蛋白(Receptor Proteins)

1.7 酶&调节子(Enzymes & Regulators)

1.8 补体系统(Complement System)

1.9 泛素相关蛋白(Ubiquitin Related Proteins)

1.10 病毒蛋白(Viral Proteins)

1.11 生物素标记蛋白(Biotinylated Proteins)

1.12 荧光标记蛋白(Fluorescent-labeled Proteins)

1.13 GMP级蛋白(GMP-grade Proteins)

1.14 其他(Others)

2   By species

2.1 人(Human)

2.2 小鼠(Mouse)

2.3 大鼠(Rat)

2.4 猴(Rhesus Macaque)

2.5 猕猴(Cynomolgus)

2.6 猪(Porcine)

2.7 狗(Canine)

2.8 牛(Bovine)

2.9 羊(Sheep)

2.10 兔(Rabbit)

2.11 猫(Cat)

2.12 病毒(Virus)

2.13 非洲爪蟾(Xenopus laevis)

2.14 其他(Others)

What is a recombinant protein?

A recombinant protein is a protein produced through genetic engineering technology, whose DNA sequence comes from genes of different origins, typically from different species. Recombinant proteins can be obtained through a series of steps such as host cell expression, purification, and crystallization.

The applications of recombinant proteins are very extensive, including the manufacture of drugs, research in life sciences, biotechnology, and other fields. For example, drugs such as human insulin, growth hormone, and interleukins are prepared through recombinant protein technology. In addition, recombinant proteins are also widely used in vaccine production, the enzyme industry, and gene therapy.


How to produce recombinant proteins?

The preparation of recombinant proteins requires a series of complex processes such as gene cloning, transfection, expression, and purification. Gene cloning refers to cloning the DNA sequence of the target gene into an expression vector. Transfection refers to introducing the recombinant expression vector into host cells. Expression refers to using the biosynthetic mechanism of the host cells to synthesize the target protein. Purification refers to using a series of physical and chemical separation techniques to purify the target protein from the complex host cells.

Recombinant proteins require an expression system for their preparation, and the ways to obtain them can be divided into pro0can and in0pro0vo methods. The premise of both methods is the application of gene recombination technology to obtain a recombinant vector connected with a gene fragment that can be translated into the target protein, and then transfer it into host cells capable of expressing the target protein to express specific recombinant protein molecules.

I20pro0can production of recombinant proteins mainly includes four major systems: prokaryotic, eukaryotic, mammalian cell, and insect cell protein systems. The choice of the appropriate expression system depends on the characteristics of the recombinant protein, the expected application of the recombinant protein, and whether the system can produce enough protein. Choose the appropriate protein expression system according tn your own downstream application to %mprove the success rate of expression.


Which expression systems are there for recombinant proteins?

The most widely used expression systems currently are three major categories: Escherichia coli (E. Coli) expression system, yeast expression system (Pichia Pastoris or P. Pastoris), and CHO cell expression system. Among them, E. coli is the most commonly used host bacterium for expressing recombinant proteins and has been used for the production of many proteins with significant medicinal value. The E. coli expression system has many advantages, such as fast growth, low culture cost, clear genetic background, and easy to achieve high-density culture.

Different expression systems and culture methods significantly affect the downstream processing process, whether the target protein forms inclusion bodies, the location of the target protein expression (inside the cell, inside the cell membrane, periplasmic space, and outside the cell), and the amount of protein expression all depend on the chosen expression system.

The proteins from HEROSTEM are mainly expressed in E. Coli, P. Pastoris, and HEK293 systems.


What are the recombinant proteins in medical cosmetology?

  • Hyaluronic Acid (HA): It is an important component naturally present in human tissues, with functions such as moisturizing, nourishing, and filling. Through genetic engineering technology, highly pure recombinant hyaluronic acid can be produced on a large scale and is widely used in medical cosmetology for injection filling and skin care;

  • Collagen: It is a protein mainly present in human connective tissue, with functions such as maintaining skin elasticity, anti-aging, and repairing damaged tissues. Recombinant collagen can be prepared through genetic engineering technology and is widely used in medical cosmetology for filling, repairing, and promoting skin regeneration. Currently, the recombinable collagens include types I, III, IV, VII, XVII, etc;

  • Botulinum Toxin (BTX): It is a neurotoxin produced by Clostridium botulinum, which can inhibit the transmission of nerve %mpulses at the neuromuscular junction, thereby achieving muscle relaxation and anti-wrinkle effects. Currently, recombinant botulinum toxin has entered the clinical stage, and HEROSTEM LAB has successfully developed a recombinant botulinum toxin of small molecules (botulinum toxin A);

  • Fibronectin (FN): It is an important structural protein present in the human body, participating in many interactions between cells and matrices. Recombinant fibronectin is widely used in the field of medical cosmetology for skin regeneration and wound healing, with functions such as promoting cell proliferation and accelerating wound healing;

  • The FGF (Fibroblast Growth Factor) family is an important class of cell growth factors, and recombinant FGF (rhFGF) has a wide range of applications in the field of medical cosmetology. rhFGF is mainly used to promote the growth and regeneration of skin cells, achieving anti-aging, repair, and beautification purposes, and has been successfully developed into a drug that accelerates wound healing.


What does "Animal-Free" mean?

Many of our protein products are labeled as "Animal-Free". Animal-Free refers to products produced in an independent production workshop without animal components, and no animal-derived materials (such as tryptone and other culture media or reagents containing animal components) are used in the production process. Therefore, it can be guaranteed that the final product does not contain any animal components, which is essential for preclinical trials and research.

Recombinant proteins are usually expressed by bacteria, and animal-derived components such as tryptone need to be added to the bacterial culture medium. These components inevitably lead to unknown animal components remaining in the terminal product. Although the purity of the terminal product can reach more than 98% or 99%, the residual %mpurities are likely to contain animal components such as tryptone. These trace components can cause the transmission of animal pathogens (such as mad cow disease virus and other unknown pathogens) to humans and animals. In addition, the heterologous proteins in these animal components can also cause xenograft rejection or allergic reactions in humans and animals. Therefore, when recombinant proteins may come into contact with the human or animal body (such as cell therapy and animal experiments), please try to choose Animal-Free recombinant proteins.


What is a "protein tag"?

A protein tag refers to a protein or polypeptide that is fused and expressed with the target protein during the preparation of recombinant proteins. Most of the recombinant protein products of HEROSTEM (including recombinant collagen) are Tag-Free, but a few recombinant protein products need to add specific tags for different purposes:

  • Tags are beneficial for protein purification;

  • When there is no specific antibody to directly identify the target protein, the tag can be used for Western Blot or ELISA analysis methods;

  • Fc tags can enhance the half-life of recombinant proteins to %mprove the stability of the molecule, and also promote the formation of active dimers of recombinant proteins.

The %mpact of recombinant protein tags on protein biological activity has is currently unknown, but in most detection applications, the tags of recombinant proteins have no effect on the biological activity of the protein itself, so there is no need to remove them. We have carried out biological activity testing on recombinant protein products and have made the data public in the CoA.


What are the contraindications for recombinant collagen?

Most of the recombinant collagen of HEROSTEM LAB is humanized type III collagen, fusion proteins after reconstruction (such as COL3FN collagen, yeast expressed), and other types of collagen (such as type IV collagen, HEK293 expressed). Although these recombinant collagens all come from human genes, it does not mean that the human body does not have an immune response to them. Therefore, before using recombinant collagen, it is necessary to ensure that the user does not have or has a lower stress response to this type of protein. The following people should avoid using recombinant collagen:

  • Patients with a history of severe allergies or autoimmune diseases;

  • Patients allergic to collagen, including (but not limited to) those who have had obvious allergic reactions when using collagen products such as collagen injections, implants, hemostatic cotton, sutures, biological glue, etc.;

  • Patients with infectious, purulent wounds, or open wounds;

  • Patients with severe keloids, coagulation dysfunction, or those taking anticoagulant drugs (such as aspirin or non-steroidal anti-inflammatory drugs), vitiligo patients are prohibited;

  • Patients with severe diabetes, severe systemic diseases, organic lesions, or those currently taking systemic disease drugs;

  • Patients with dermatitis, allergic skin, skin viral %nfections, or those who cannot tolerate this treatment method should be cautious;

  • Special attention: Women should avoid pregnancy, lactation, and menstruation;

  • People who are often exposed to ultraviolet rays;

  • Patients who have received facial treatment or skin care within 30 days should follow the doctor's advice;

  • Patients who are positive for COVID-19 or have recovered from COVID-19 within 30 days.

What is the QC for recombinant human collagen?

Gene sequence: analyzed by N-terminal sequence. If necessary, use SDS-PAGE, HPLC, and mass spectrometry to compare with the standards;

Purity:

  • Via SDS-PAGE

  • HPLC analysis

Bio-activity: as determined by relevant in o0can or in%pro0vo bioactivity assays, as detailed below;

Protein concentration:

  • Ultraviolet spectrophotometry

  • Quantitative determination of BCA protein

  • SDS-PAGE analysis

  • Comparison of HPLC methods with standards

Endotoxin: determined by dynamic LAL (Western LAL reagent) method or TAL (Eastern LAL reagent) method;

Sterility: All protein solutions are filtered and sterilized by 0.22um filter membrane before lyophilization, and then packaged, lyophilized and capped in a B+A environment;

Molecular weight: SDS-PAGE analysis;

Host protein residue: fluorescent staining;

Host DNA residue: ELISA kit;

Mycoplasma: Mycoplasma kit.


What is bio-activity of protein?

The biological activity of a protein is a manifestation of its various functions. A protein must have activity to perform its function. Proteins that possess biological activity are referred to as active proteins, that is, proteins that exhibit biological activity. In theory, all naturally occurring proteins are active, but recombinant proteins are not always active because the production of recombinant proteins is a complex process, and many factors are crucial to their biological activity, such as an ideal expression system, a suitable expression vector, and purification method, etc.


1. Calculation of ED50:


The ED50 of our protein (i.e., the concentration of the protein that causes a 50% maximum response in specific cells, measured in ng/mL) can be obtained from the Certificate of Analysis (COA) of the product. This method of expressing activity is only applicable to cytokines whose dose-response curves are sigmoidal. Defining 1 ng/mL ED50 as 1 unit, the formula for converting the product's biological activity, Specific Activity, is as follows:


Specific Activity(units/mg) = 1 × 10 6  ÷  ED50(ng/mL)

The formula above is not applicable for converting between International Units (IU) and ED50.


IU system is part of an older system of measuring biological activity, often used for substances like hormones, vitamins, and certain enzymes. The IU is defined relative to a standard preparation that has a known activity. For example, the IU for insulin is based on a standard that has been established by international agreement.


To convert ED50 to IU, you would typically need to compare the biological activity of your protein preparation to that of the international standard. This is done by running a parallel assay where both your preparation and the standard are tested. The activity of your preparation is then calculated relative to the standard, and IU are assigned based on this comparison.


The exact method of conversion can vary depending on the specific protein and the nature of the biological activity being measured. Therefore, it's important to follow established protocols and guidelines for the protein in question to ensure accurate and meaningful comparisons.


2. Factors Affecting ED50:

The experimental protocols in the product manual are solely for confirming the product's ED50. If the customer's experimental type is identical to ours, experiments can be conducted based on the biological activity calibrated for the product. Should the experiment utilize different cell types or methods, we advise customers to determine the optimal ED50 value through experiments with gradient concentrations and to formulate corresponding experimental plans and product dosages based on this value. For any inquiries regarding biological activity or experimental methods, please contact our technical support at Support@herostem.com.cn.


Precautions for using recombinant collagen

  • Mild erythema, swelling, and bruising are normal and typically resolve within 2-3 days post-procedure;

  • Avoid contact with water for 12 hours after facial application, and if necessary, clean with saline solution;

  • Within one week after use, adhere to "three protections and one prohibition": protect against dust, sun, and irritation, and refrain from using functional skincare products;

  • Maintain a light diet and avoid seafood and spicy, irritating foods;

  • Abstain from alcohol during the treatment period;

  • Use sterile repair products morning and night for one week after use to enhance hydration and sun protection measures;

  • If co-administered with other products, ensure that the co-administered products are completely sterile and free from protease residue, as proteases can cleave collagen;

  • Due to the potential for lidocaine to bind with proteins or sugars and alter protein characteristics, co-administration of recombinant collagen with lidocaine is prohibited.

What is protein denaturation?

Under the influence of certain physicochemical factors, the specific spatial structure of a protein is disrupted, leading to changes in its original physicochemical properties and loss of biological activity. This phenomenon is known as protein denaturation, and such proteins are referred to as denatured or inactive proteins.

The process of protein denaturation is typically irreversible. Denatured proteins are usually solids that are insoluble in water and other solvents. They also lose the characteristics of the original proteins. In other words, denatured proteins lack biological activity and no longer perform specific biological functions. For enzymes, they lose their catalytic ability. The main causes of denaturation are heat, ultraviolet light, vigorous stirring, strong acids, and alkalis.


How to address co-production of recombinant proteins?

We have established a strict quality system that manages product production in accordance with the "Guidelines for Quality Risk Management of Co-line Production of Pharmaceuticals" issued by the National Medical Products Administration. This ensures the utmost reduction, and even elimination, of contamination and cross-contamination caused by co-line production, ensuring the safety, efficacy, and controllable quality of our products, and ensuring that our customers can safely use our products.


Transportation and Storage Methods for Recombinant Proteins?

Storage:

  • Recombinant collagen preparations are relatively stable at room temperature and can be stored for over 2 years at room temperature;

  • Once the product is opened, it must be used within 1 hour;

  • If co-formulated with other products, ensure that the co-formulated products are completely sterile and free from protease residue, as proteases can cleave collagen.

Transportation:

Under normal circumstances proteins are shipped with blue ice or under room temperature. Some products may be shipped with dry ice, such as recombinant nucleases, trypsin, etc.


Other Questions

If you have any questions about products from HEROSTEM, please feel free to contact our sales department at client@herostem.com.cn or 4009-204-254.